A human inhibitor of tumor necrosis factor alpha - PubMed (original) (raw)
A human inhibitor of tumor necrosis factor alpha
P Seckinger et al. J Exp Med. 1988.
Abstract
Urine of some febrile patients exhibits a TNF-alpha inhibitory activity (TNF-alpha INH), sensitive to heat and trypsin, with an apparent mol wt of 40-60 X 10(3) and a pI range of 5.5-6.1. As for the Il-1 INH, the TNF INH activity involves a competitive mechanism of action suggesting the existence of a family of negative feedback-regulating molecules interfering with cytokines actions.
Similar articles
- Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor.
Seckinger P, Zhang JH, Hauptmann B, Dayer JM. Seckinger P, et al. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5188-92. doi: 10.1073/pnas.87.13.5188. Proc Natl Acad Sci U S A. 1990. PMID: 2164226 Free PMC article. - Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor.
Seckinger P, Isaaz S, Dayer JM. Seckinger P, et al. J Biol Chem. 1989 Jul 15;264(20):11966-73. J Biol Chem. 1989. PMID: 2545692 - A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha.
Seckinger P, Williamson K, Balavoine JF, Mach B, Mazzei G, Shaw A, Dayer JM. Seckinger P, et al. J Immunol. 1987 Sep 1;139(5):1541-5. J Immunol. 1987. PMID: 3040855 - Tumor necrosis factor inhibitor: purification, NH2-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activities.
Seckinger P, Vey E, Turcatti G, Wingfield P, Dayer JM. Seckinger P, et al. Eur J Immunol. 1990 May;20(5):1167-74. doi: 10.1002/eji.1830200533. Eur J Immunol. 1990. PMID: 2113477 - TNF inhibitor with a low molecular weight found in the human sera.
Shimoda A, Hanaumi K, Kumagai K. Shimoda A, et al. Tohoku J Exp Med. 1995 Dec;177(4):327-35. doi: 10.1620/tjem.177.327. Tohoku J Exp Med. 1995. PMID: 8928192
Cited by
- Cytokines, receptors, and inhibitors.
Gehr G, Braun T, Lesslauer W. Gehr G, et al. Clin Investig. 1992 Jan;70(1):64-9. doi: 10.1007/BF00422944. Clin Investig. 1992. PMID: 1318126 Review. - Tumour necrosis factor soluble receptors behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritis.
Chikanza IC, Roux-Lombard P, Dayer JM, Panayi GS. Chikanza IC, et al. Clin Exp Immunol. 1993 Apr;92(1):19-22. doi: 10.1111/j.1365-2249.1993.tb05941.x. Clin Exp Immunol. 1993. PMID: 8385584 Free PMC article. - Release of monokines by pulmonary macrophages following antigen challenge in sensitized guinea pigs.
Denis M, Kelly DE, Biggs DF. Denis M, et al. Inflammation. 1994 Aug;18(4):349-60. doi: 10.1007/BF01534433. Inflammation. 1994. PMID: 7982726 - Etanercept: a review of its use in rheumatoid arthritis.
Jarvis B, Faulds D. Jarvis B, et al. Drugs. 1999 Jun;57(6):945-66. doi: 10.2165/00003495-199957060-00014. Drugs. 1999. PMID: 10400407 Review. - Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture.
Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM. Kwiatkowski D, et al. Clin Exp Immunol. 1989 Sep;77(3):361-6. Clin Exp Immunol. 1989. PMID: 2680183 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666-70 - PubMed
- J Immunol. 1985 Oct;135(4):2492-7 - PubMed
- Nature. 1985 Aug 8-14;316(6028):552-4 - PubMed
- J Exp Med. 1985 Dec 1;162(6):2163-8 - PubMed
- Ann Inst Pasteur Immunol. 1987 May-Jun;138(3):486-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous